{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:18Z","timestamp":1792189158248,"version":"4.4.0"},"reference-count":25,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Surgical Infections"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with fungal pneumonias sometimes progress to acute respiratory distress syndrome (ARDS). Mortality has been reported as high as 60% to 90% in this group. Venovenous extracorporeal membrane oxygenation (VV-ECMO) can be used to support such patients, however, outcomes are not well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>This was a retrospective study across the four adult ECMO centers in Minnesota for one decade (2012\u20132022). The outcomes of interest were duration of ECMO, survival rate, and complications. Data were extracted from the electronic medical record and analyzed using descriptive statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fungal pneumonia was the etiology of ARDS in 22 of 422 (5%) adults supported with VV-ECMO during the 10-year study period. Median patient age was 43 years (interquartile range [IQR], 35\u201356) and 68% were male. By type of fungal infection, 16 (72%) had blastomycosis, five (22%) had pneumocystis, and one (5%) had cryptococcus. Of the 16 patients with blastomycosis two were immunosuppressed whereas all five of the pneumocystis patients were immunosuppressed. The overall survival rate was 73%; most patients with blastomycosis (67%) and pneumocystis (80%) survived to hospital discharge. The duration of ECMO support was greater for the pneumocystis group (median, 30 days; IQR, 21\u201343) compared with blastomycosis (median, 10 days; IQR, 8\u201318).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings support the use of VV-ECMO for ARDS caused by fungal pneumonias in select immunocompetent and immunocompromised patients. Although survival was high, patients with pneumocystis required longer ECMO runs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/sur.2023.083","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T11:39:07Z","timestamp":1692358747000},"page":"632-636","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of Venovenous Extracorporeal Membrane Oxygenation in Patients With Acute Respiratory Distress Syndrome Caused by Fungal Pneumonia"],"prefix":"10.1177","volume":"24","author":[{"given":"Bridget","family":"Dillon","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Wothe","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota, USA."},{"name":"Department of Critical Care, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA."},{"name":"Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA."},{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danika","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA."},{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Damroth","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bohman","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Saavedra-Romero","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Prekker","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA."},{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Brunsvold","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2017.04.006"},{"key":"e_1_3_3_3_2","article-title":"Pneumocystis jirovecii pneumonia","author":"Truong J","year":"2022","unstructured":"Truong J, , Ashurst JV. Pneumocystis jirovecii pneumonia. StatPearls; 2022.","journal-title":"StatPearls"},{"key":"e_1_3_3_4_2","unstructured":"Minnesota Department of Health. Blastomycosis (Blastomyces dermatitidis and Blastomyces gilchristii). 2022. Available from: https:\/\/www.health.state.mn.us\/diseases\/blastomycosis [Last accessed: May23 2023]."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2021.03.012"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0289"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198601000-00001"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/514984"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2512"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/adpa.2001.21473"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310213291704"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.2.436"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.2.9909014"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003538"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2008-740ST"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.5768"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2778"},{"issue":"4","key":"e_1_3_3_18_2","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection","volume":"2015","author":"Ewald H","year":"2015","unstructured":"Ewald H, , Raatz H, , Boscacci R, et al. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev, 2015; 2015(4):CD006150; doi: 10.1002\/14651858.CD006150.PUB2","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2348"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-015-0378-z"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000000374"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2221-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-229612"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof8040415"}],"container-title":["Surgical Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/sur.2023.083","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2023.083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2023.083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:30:01Z","timestamp":1777689001000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/sur.2023.083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9,1]]}},"alternative-id":["10.1089\/sur.2023.083"],"URL":"https:\/\/doi.org\/10.1089\/sur.2023.083","relation":{},"ISSN":["1096-2964","1557-8674"],"issn-type":[{"value":"1096-2964","type":"print"},{"value":"1557-8674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}